| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate |
1987-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3933c70e143857e9ad1af554585dfc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8e73217685ef2060b47941f2ad0457b |
| publicationDate |
1988-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0256629-A2 |
| titleOfInvention |
Tolrestat or a salt thereof as an immuno-stimulating agent |
| abstract |
A method is disclosed for stimulating the immune response in a human subject to an increased risk of infection and requiring restoration of the immune response by administering an effective amount of tolrestat or a salt thereof. Tolrestat or its salt can be used in the preparation of a medicament for stimulating the immune response. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5340829-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0536119-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021202523-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590131-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0536119-A4 |
| priorityDate |
1986-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |